A new technique allowed researchers to label with specificity proteins inside neurons of the striatum — a brain region involved…
Articles by Patricia Inácio, PhD
A Phase 1 clinical trial in the U.K. is recruiting patients with mild to moderate Parkinson’s to assess…
An upcoming Australian study will investigate the potential benefits of pool walking — walking in a swimming pool versus on…
The Parkinson’s Foundation has awarded over $2.2 million in community health grants to 143 programs that will benefit Parkinson’s disease patients across…
Forest Hills Lab announced that it has U.S. Food and Drug Administration (FDA) permission to open a Phase 2 trial into…
The U.S. Food and Drug Administration (FDA) has given fast track designation to the investigational cell therapy DA01, now in a clinical…
Ipsen has entered into an exclusive worldwide licensing agreement with Integrative Research Laboratories (IRLAB) to develop and commercialize…
A £1.375 ($1.9) million grant from the Edmond J. Safra Foundation will support a pioneering clinical trial aimed at speeding the development…
The U.S. Food and Drug Administration (FDA) has approved a Phase 3 trial to test multiple infusions of fat-derived mesenchymal…
Aleva Neurotherapeutic’s innovative directional deep brain stimulation (DBS) system — called directSTIM — for Parkinson’s disease has been…